FKD Therapies Oy

The list of companies that have made money out of a gene therapy is extremely short but Ferring Pharmaceuticals has a case for inclusion given the sales growth last year of its bladder cancer treatmen

CG Oncology believes that the Phase III data for its oncolytic immunotherapy for bladder cancer show that cretostimogene grenadenorepvec can spare patients bladder surgery, and analysts said the data

Just shy of three years after Ferring Pharmaceuticals and Blackstone formed FerGene to advance the late-stage bladder cancer gene therapy nadofaragene firadenovec, the pharma company and the priva

The field of cell, gene and tissue therapies, now known as regenerative medicine, has seen tremendous and sustained growth in discovery and early-stage development in recent years, but the pipeline of